Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-022777

Chief Executive Officer acquired 576,452 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

De Backer Marianne · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-03 Grant or award : show line 1 in the form +576,452 576,452 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +1,152,904 1,152,904 D
Loading xslF345X04/doc4.xml…